Dr. ASLIHAN CANDEVİR

1. Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study.

Demirel Ç., Kibar F., Dağlıoğlu G., Çetiner S., Candevir A., Inal A. S., et al.

Medical science monitor : international medical journal of experimental and clinical research , cilt.32, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Pulmonary complications in people living with HIV: a retrospective evaluation of the etiological spectrum and mortality-associated factors.

Ertürk D., Candevir A., Akkaya A., Kömür S., Acar O., Kuşçu F., et al.

BMC infectious diseases , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Assessment of awareness and use of electronic cigarettes among people living with HIV

Ertürk D., Bavli K., Kusçu F., Çetinkaya P., Candevir A., Kömür S., et al.

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV , 2026 (SSCI, Scopus)

4. Hepatitis B Vaccination Rates and Risk Factors Affecting Vaccine Response in People Living with HIV in Turkey

Mirza A., ÇABALAK M., GÜNAL Ö., CANDEVİR A., Kayaaslan B., Karaoğlan İ., et al.

Current HIV Research , 2026 (SCI-Expanded, Scopus)

5. HIV and Pregnancy in Türkiye: Gaps and Gains in the Era of Modern ART: A Multicenter Cohort Study

Damar Çakırca T., Kurtaran B., Aydın Ö., KAYAASLAN B., Kaya B., Karaoğlan İ., et al.

AIDS and Behavior , 2026 (SSCI, Scopus)

6. Effect of Promoter Region Polymorphisms in the IP-10 Gene on HBsAg Loss in Chronic Hepatitis B Patients

Tutku Kaçar Şahin M., Burak Bereketoğlu M., Dogan H., Kose M., Kuşcu F., Kurtaran B., et al.

HEPATITIS MONTHLY , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

7. Routine hemoglobin-A1c screening is required before the next pandemic to reduce morbidity and in-hospital costs

Saygideğer Y., Candevir A., Curuk B., Altunok E., Demir M. S., Güzel E., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , cilt.19, sa.9, ss.1330-1335, 2025 (SCI-Expanded, Scopus)

8. Menopoz ve İmmunite Üzerine Bir Derleme

Gungor A. N. C., Candevir A.

Arşiv Kaynak Tarama Dergisi , cilt.34, sa.2, ss.156-161, 2025 (TRDizin)

9. Latent Tuberculosis Screening and Active Tuberculosis Disease Development in People Living with HIV: A Multicenter Retrospective Cohort Study in Turkiye

Kuşcu F., Yildirim F., Erturk D., Çabalak M., Komur S., İnal A. S., et al.

CURRENT HIV RESEARCH , cilt.23, sa.1, ss.69-75, 2025 (SCI-Expanded, Scopus)

10. Evaluation of Candidemia Epidemiology and Mortality Risk Factors in a Tertiary Hospital: An 11-Year Retrospective Study

Solmaz N., KUŞCU F., CANDEVİR A., Kömür S., Kurtaran B., İNAL A. S., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.30, sa.1, ss.79-90, 2025 (ESCI, TRDizin)

11. A Comparative Analysis of COVID-19-Associated and Non-COVID-19-Associated Mucormycosis

Kömür S., Candevir A., İnal A., Kuşcu F., Kurtaran B., Memişoğlu F., et al.

Endocrine Metabolic & Immune Disorders - Drug Targets , cilt.25, 2025 (Scopus)

12. Follow-up evaluation of long COVID syndrome in patients with SARS-CoV-2 infection

Sevdimbas S., İnal A. S., Kuşcu F., Kurtaran B., Candevir A., Tasova Y., et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL , cilt.58, 2025 (SCI-Expanded, Scopus)

13. Nedeni Bilinmeyen Ateşle Takip Edilen Bir Olguda Saptanan Coxiella burnetii Endokarditi: Q Ateşi Olgusu

Hoşgel Sevdimbaş S., Kurtaran B., Candevir A., Kuşcu F., Taşova Y.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.4, ss.540-544, 2024 (ESCI, TRDizin)

14. Effect of galectin-3, IL-1, IL-6 and TNF-alpha on disease prognosis and mortality in COVID-19 patients

Demir M. S., KUŞCU F., KURTARAN B., CANDEVİR A., İNAL A. S., KÖMÜR S., et al.

Journal of Infection in Developing Countries , cilt.18, sa.9, 2024 (SCI-Expanded, Scopus)

15. Yeni Tanı Bir HIV Olgusunda Norveç Uyuzu

Üstüner Doğan M., Kurtaran B., Candevir A.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.3, ss.403-404, 2024 (ESCI, TRDizin)

16. Central Line Associated Bloodstream Infections Outside the Intensive Care Unit: A 2-Year Analysis

Candevir A., Kurtaran B., Kuşcu F., Kömür S., Kibar F., Ertürk D., et al.

Scientific Reports in Medicine , cilt.1, sa.1, ss.9-17, 2024 (Hakemli Dergi)

17. Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.

Çelen M. K., Ertürk Şengel B., Kaya Ş., Demirtürk N., Azap A., Pullukçu H., et al.

Journal of infection in developing countries , cilt.18, sa.3, ss.441-449, 2024 (SCI-Expanded, Scopus)

18. Cryptococcus Antigen Positivity in Newly Diagnosed HIV-Positive Individuals: A Retrospective Evaluation Using the Lateral Flow Assay Method

KUŞCU F., Bıkmaz A. Ç., İLKİT M. M., KARAKOYUN A. S., CANDEVİR A., KÖMÜR S., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.4, ss.526-533, 2024 (ESCI, TRDizin)

19. Changing Epidemiology of Chronic Hepatitis C: A University Hospital Experience

KÖMÜR S., KURTARAN B., ARSLAN Y. K., KUŞCU F., Sevdimbaş S. H., Inal S. A., et al.

Hepatitis Monthly , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

20. Evaluation of HIV and Syphilis Co-infected Cases, Data from a University Hospital

KÖMÜR S., Ertürk D., Sevdimbaş S., KUŞCU F., İNAL A. S., KURTARAN B., et al.

Current HIV Research , cilt.22, sa.3, ss.153-157, 2024 (SCI-Expanded, Scopus)

21. Coxiella burnetii Endocarditis Detected in a Case Followed with Fever of Unknown Reason: Q Fever Case Report

Hosgel Sevdimbas S., Kurtaran B., CANDEVİR A., KUŞCU F., Tasova Y.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.29, sa.4, ss.540-544, 2024 (ESCI, TRDizin)

22. The Role of Calprotectin and Alpha-Defensin in the Diagnosis of Pneumonia in Ventilated Patients

Özkan D. Ö., Bayrakçı S., Etiz P., Karakoc E., Goruroglu Ozturk O., Ozyılmaz E., et al.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , cilt.28, sa.3, ss.518-526, 2023 (ESCI, TRDizin)

23. Late Diagnosis in HIV with New and Old Definitions; Data from a Regional Hospital in Turkey.

Candevir A., Kuscu F., Kurtaran B., Kömür S., Inal A. S., Ertürk D., et al.

International journal of general medicine , cilt.16, ss.4227-4234, 2023 (SCI-Expanded, Scopus)

24. Exposure to COVID-19 among unvaccinated healthcare personnel and risk for infection: a single-center retrospective study.

Candevir A., Ertürk D., Kuşcu F., Kömür S., Saygideğer Y., Inal A. S., et al.

Journal of infection in developing countries , cilt.17, sa.8, ss.1081-1087, 2023 (SCI-Expanded, Scopus)

25. Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data.

Sarıgül Yıldırım F., Candevir A., Akhan S., Kaya S., Çabalak M., Ersöz G., et al.

International journal of general medicine , cilt.16, ss.1867-1877, 2023 (SCI-Expanded, Scopus)

26. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)-based survey.

Azak E., Sertcelik A., Ersoz G., Celebi G., Eser F., Batirel A., et al.

Antimicrobial resistance and infection control , cilt.12, sa.1, ss.11, 2023 (SCI-Expanded, Scopus)

27. Comparison of Levels of Nephropathy Biomarkers in HIV-infected Individuals and Healthy Volunteers

Ertürk D., Candevir A., Kömür S., Kuşcu F., İnal A. S., Kurtaran B., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, TRDizin)

28. HIV ile Yaşayan Bireylerin COVID-19 Salgınında Sağlık Hizmetine ve İlaçlara Erişimi ile İlgili Yaşadıkları Sorunlar ve Kaygı Düzeylerinin Değerlendirilmesi

Ertürk D., Kuşcu F., Kaçar M. T., İnal A. S., Candevir A., Kömür S., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.27, sa.4, ss.609-617, 2022 (TRDizin)

29. Febril Nötropenide Fungal Pnömonilerin Yeri, Klinik ve Mikrobiyolojik Özellikleri

GÜL DUMAN Z., KURTARAN B., KİBAR F., KÖMÜR S., BAYDAR TOPRAK O., KUŞCU F., et al.

Fırat Tıp Dergisi , cilt.27, sa.4, ss.262-268, 2022 (TRDizin)

30. CORRELATION OF PATIENT FEATURES OF COVID-19, LABORATORY TESTS AND COMPUTED TOMOGRAPHY FINDINGS: SINGLE-CENTER RETROSPECTIVE STUDY

KÖSE S., PEHLİVAN U. A., KUŞCU F., SAYGIDEĞER Y., BAYDAR TOPRAK O., ONAN H. B., et al.

Çukurova Anestezi ve Cerrahi Bilimler Dergisi , cilt.5, sa.3, ss.288-294, 2022 (TRDizin) Sürdürülebilir Kalkınma

31. Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?

Kara E., Tanır F., Demirhindi H., Mete B., Kibar F., Çetiner S., et al.

MIKROBIYOLOJI BULTENI , cilt.56, sa.3, ss.566-573, 2022 (SCI-Expanded, Scopus, TRDizin)

32. COVID Yoğun Bakım Ünitesinde Gelişen Nozokomiyal İnfeksiyonlar ve Özellikleri Incidence and Clinical Characteristics of Nosocomial Infections in COVID Intensive Care Unit

BAYDAR TOPRAK O., CANDEVİR A., KÖMÜR S., KUŞCU F., İNAL A. S., SAYGIDEĞER Y., et al.

FLORA İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , cilt.27, sa.2, ss.317-323, 2022 (Hakemli Dergi)

33. Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study

Demirhindi H., Mete B., Tanır F., Kara E., Kibar F., Çetiner S., et al.

VACCINES , cilt.10, sa.5, 2022 (SCI-Expanded, Scopus)

34. SARS-COV-2 vaccine: First-month results of a six-month follow-up study.

Mete B., Tanir F., Demirhindi H., Kara E., Kibar F., Çetiner S., et al.

Turkish journal of medical sciences , cilt.52, ss.21-31, 2022 (SCI-Expanded, Scopus, TRDizin)

35. How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic.

Candevir A., Üngör C., Çizmeci Şenel F., Taşova Y.

Turkish journal of medical sciences , cilt.51, sa.SI-1, ss.3238-3245, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Comparison of Candida Polymerase Chain Reaction Method and Blood Culture in Patients with High Risk of Candidemia in Intensive Care Unit

Şimşek Bozok T., Kuşcu F., Bozok T., Kömür S., Candevir A., Seza İnal A. S., et al.

MIKROBIYOLOJI BULTENI , cilt.55, sa.4, ss.568-579, 2021 (SCI-Expanded, Scopus, TRDizin)

37. Covid-19 hastalarında Eozinofil / Lenfosit ve D-Dimer/ Fibrinojen oranlarının hastalık seyri ile ilişkisi

Saygıdeğer Y., Candevir A., Özkan H., Kömür S., Sancıoğlu Demir M.

Mersin Üniversitesi Sağlık Bilimleri Dergisi , cilt.14, sa.2, ss.307-319, 2021 (TRDizin) Sürdürülebilir Kalkınma

38. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.

Tanriover M. D., Doğanay H. L., Akova M., Güner H. R., Azap A., Akhan S., et al.

Lancet (London, England) , cilt.398, sa.10296, ss.213-222, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients

Aydemir D., Dağlıoğlu G., Ulu A., Kurtaran B., Bozdogan S., İnal T. C., et al.

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , cilt.40, sa.5, ss.505-517, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Physicians' knowledge of potential covid-19 drug-drug interactions: An online survey in turkey.

SÜRMELİOĞLU N., YALÇIN N., KUŞCU F., Candevir A., İNAL A. S., KÖMÜR S., et al.

Postgraduate medicine , cilt.133, sa.2, ss.237-241, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Low immunity against vaccine preventable diseases in Turkish HIV cohort

Candevir A., Kuşcu F., Yildirim F., Kömür S., Çiçek Şentürk G., Inal A. S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2311-2317, 2021 (SCI-Expanded, Scopus, TRDizin)

42. Spondylodiscitis due to Methiciflin-Resistant Staphylococcus aureus in a Patient with Hyperimmunoglobulin E Syndrome (Job's Syndrome)

Kacar M. T., Yardimci O. F., KUŞCU F., KURTARAN B., CANDEVİR A., KÖMÜR S., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.26, sa.4, ss.762-766, 2021 (ESCI, TRDizin)

43. COVID-19 patients' sera induce epithelial mesenchymal transition in cancer cells.

Saygıdeğer Y., Sezan A., Candevir A., Saygıdeğer Demir B., Güzel E., Baydar O., et al.

Cancer treatment and research communications , cilt.28, ss.100406, 2021 (Scopus)

44. The diagnostic cut off value of Lung Ultrasound Score to differentiate Hospital Acquired/Ventilator Associated Pneumonia and Hospital Acquired/Ventilator Associated Tracheobronchitis

ÖZYILMAZ E., Bayrakci S., Kuscu O., Saygili N. B., Candevir A., ETİZ P., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.56, 2020 (SCI-Expanded, Scopus)

45. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae at a Turkish centre: Is the increase of resistance a threat for Europe?

Ulu A., GOKMEN T. G., KİBAR F., KURTARAN B., Önlen C., KUŞCU F., et al.

Journal of global antimicrobial resistance , cilt.11, ss.10-16, 2017 (SCI-Expanded, Scopus)

46. Furuncular Myiasis Caused by Dermatobia hominis in a Traveler Returning from the Amazon Jungle.

Kuşcu F., Özsoy K. M., Ulu A., Kurtaran B., Kömür S., İnal A. S., et al.

Turkiye parazitolojii dergisi , cilt.41, ss.173-176, 2017 (Scopus, TRDizin)

47. Toxoplasma encephalitis: an HIV / AIDS patient with cerebral mass

İNAL A. S., Nazik S., Candevir A., KURTARAN B., TAŞOVA Y., Aksu H. S. Z.

CUKUROVA MEDICAL JOURNAL , cilt.42, sa.1, ss.184-188, 2017 (ESCI, TRDizin) Sürdürülebilir Kalkınma

48. Çocuk yoğun bakım ünitesinde uygulanan ventilatörle ilişkili pnömoni önlem paketinin etkinliği

Türkoğlu B., Ulu A., Özgür Horoz Ö., Kömür M., Yıldızdaş R. D., Taşova Y.

Hastane İnfeksiyonları Dergisi , cilt.20, sa.1, ss.165-187, 2016 (Hakemli Dergi)

49. Mucormycosis: a 10-year experience at a tertiary care center in Turkey

KÖMÜR S., İNAL A. S., KURTARAN B., ULU A., UGUZ A., AKSU H. S. Z., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.1, ss.58-62, 2016 (SCI-Expanded, Scopus, TRDizin)

50. Erişkin Bir Hastada El, Ayak ve Ağız Hastalığı

KUŞCU F., KÖMÜR S., ULU A.

Flora , cilt.2, sa.21, ss.93-94, 2016 (SCI-Expanded, Scopus)

51. Protez Eklem İnfeksiyonlarında Etkenler, Tedavi Rejimleri ve Prognozun Değerlendirilmesi

ULU A., Şele K., KUŞCU F., KURTARAN B., İNAL A. S., ÇİFTLER KÖMÜR S., et al.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , cilt.21, sa.4, ss.159-168, 2016 (TRDizin)

52. Protez Eklem İnfeksiyonlarında Etkenler, Tedavi Rejimleri ve Prognozun Değerlendirilmesi

ULU A., Şele K., KUŞCU F., KURTARAN B., İNAL A. S., ÇİFTLER KÖMÜR S., et al.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , cilt.21, sa.4, ss.159-168, 2016 (TRDizin)

53. Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study.

Yildiz S. M., Candevir A., KİBAR F., Karaboga G., Turhan F. T., Kis C., et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.53, sa.3, ss.308-14, 2015 (SCI-Expanded, Scopus)

54. Plasmapheresis in the Treatment of Acute Liver Failure: A Case Report and a Review of the Literature

Ulu A., KURAN S., KURTARAN B., İNAL A. S., KÖMÜR S., TEKINTURHAN F., et al.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.21, sa.3, ss.98-101, 2015 (ESCI, TRDizin) Sürdürülebilir Kalkınma

55. Candida peritonitis unrelated with continuous ambulatory peritonea dialysis (CAPD) in adult patients in a Turkey hospital

KURTARAN B., KİBAR F., ULU A., İNAL A. S., KÖMÜR S., SAKMAN G., et al.

MYCOSES , cilt.58, ss.93, 2015 (SCI-Expanded, Scopus)

56. Vitamin D Levels and Hepatitis B: Is There Any Relationship?

Ulu A., KUŞCU F., İNAL A. S., KÖMÜR S., KURTARAN B., NAZIK S., et al.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.21, sa.2, ss.44-47, 2015 (ESCI, TRDizin) Sürdürülebilir Kalkınma

57. İnşaat ile Gelen İnfeksiyon Riskleri

TAŞOVA Y., BİLGİN A., CANDEVİR ULU A.

Hastane İnfeksiyonları Dergisi , cilt.19, sa.1, ss.12-22, 2015 (Hakemsiz Dergi)

58. Evaluation of Hiv Infection And Tuberculosis Concomitance

KURTARAN B., NAZİK S., ULU A., İNAL A. S., KÖMÜR S., KUŞCU F., et al.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.4, 2015 (ESCI, Scopus) Sürdürülebilir Kalkınma

59. Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C

KÖMÜR S., İNAL A. S., Ulu A. C., KURTARAN B., TAŞOVA Y., Salih H., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.6, ss.702-706, 2014 (SCI-Expanded, Scopus, TRDizin)

60. EARLY TREATMENT RESULTS OF TELAPREVIR BASED TRIPLE REGIMENS IN CHRONIC HEPATITIS C PATIENTS IN TURKEY

AKSU F., KURTARAN B., INAL A. S., ULU A., Koemuer S., TASOVA Y., et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.115, ss.227, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Normal Mikrobiyal Floranın İnsan Sağlığı Üzerine Etkisi ve İnsan Mikrobiyom Projesi

BOZOK T., ŞİMŞEK T., KÖMÜR S., ULU A.

Arşiv Kaynak Tarama Dergisi , cilt.23, sa.3, ss.420-423, 2014 (TRDizin)

62. Nörolojik sekelle sonuçlanan Herpes ensefaliti:olgu sunumu.

KÖMÜR S., KURTARAN B., İNAL A. S., ULU A., TAŞOVA Y., AKSU H. Z.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.3, sa.2, ss.1-4, 2014 (ESCI, Scopus)

63. Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort

KİBAR F., Ozturk O. G., ULU A., ERKEN E., Inal S., DİNKÇİ S., et al.

MEDICAL SCIENCE MONITOR , cilt.20, ss.28-34, 2014 (SCI-Expanded, Scopus)

64. Herpes Encephalitis Resulting in Neurologic Sequelae: Case Report

ÇİFTLER KÖMÜR S., KURTARAN B., İNAL A. S., ULU A., TAŞOVA Y., AKSU H. Z.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.3, sa.2, ss.1-4, 2014 (ESCI, Scopus)

65. 2009 2013 Yılları Arası Daptomisin Deneyimi 139 Hastanın Değerlendirilmesi

KÖMÜR S., KURTARAN B., İNAL A. S., CANDEVİR ULU A., TAŞOVA Y., AKSU H. S. Z.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.3, sa.23, ss.1-8, 2014 (ESCI, Scopus)

66. Changing Epidemiology of Chronic Hepatitis C in Adana

KUŞCU F., ÇİFTLER KÖMÜR S., İNAL A. S., ULU A., KURTARAN B., TAŞOVA Y., et al.

Viral Hepatitis Journal , cilt.20, sa.1, ss.15-18, 2014 (Hakemli Dergi) Sürdürülebilir Kalkınma

67. Withdrawal of Staphylococcus aureus from intensive care units in Turkey

ERDEM H., Dizbay M., KARABEY S., KAYA S., Demirdal T., Koksal I., et al.

AMERICAN JOURNAL OF INFECTION CONTROL , cilt.41, sa.11, ss.1053-1058, 2013 (SCI-Expanded, Scopus)

68. Determination of Quality of Life and Their Perceived Social Support from Family of Patients with HIV/AIDS

Nazik E., Arslan S., Nazik H., KURTARAN B., NAZİK S., ULU A., et al.

SEXUALITY AND DISABILITY , cilt.31, sa.3, ss.263-274, 2013 (SSCI, Scopus) Sürdürülebilir Kalkınma

69. 2007 DEN 2011 E STENOTROPHOMONAS MALTOPHİLİA İNFEKSİYONLARI

ULU A., KURTARAN B., KİBAR F., İNAL A. S., KÖMÜR S., AKSU H. S. Z., et al.

Flora Dergisi , cilt.18, sa.3, ss.119-127, 2013 (Hakemli Dergi)

70. 2007 den 2011 e Stenotrophomonas maltophilia infeksiyonları

ULU A., KURTARAN B., KİBAR F., İNAL A. S., KÖMÜR S., AKSU H. S. Z., et al.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.18, sa.3, ss.119-127, 2013 (TRDizin)

71. Clinical appearance of brucellosis in adults: fourteen years of experience

KURTARAN B., Candevir A., İNAL A. S., KÖMÜR S., AKYILDIZ O., Saltoglu N., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.42, sa.3, ss.497-505, 2012 (SCI-Expanded, Scopus, TRDizin)

72. Pseudomonas aeruginosa infections due to electronic faucets in a neonatal intensive care unit

Yapicioglu H., Gokmen T., Yıldızdas D., Köksal F., Ozlu F., Kale-Cekınmez E., et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH , cilt.48, sa.5, ss.430-434, 2012 (SCI-Expanded, Scopus)

73. The place and the efficacy of infectious disease consultations in the hospitals

Erdem H., Kurtaran B., Arun Ö., Ylmaz H., Çelebi G., Özkaya H. D., et al.

Infectious Diseases in Clinical Practice , cilt.20, ss.131-136, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. A Case of HIV Infection with Thrombocytopenia: Assosiation of HIV, Thrombotic Thrombocytopenic Purpura and Brucellosis

KURTARAN B., OTO O. A., Candevir A., İNAL A. S., SIRIN Y.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.27, sa.1, ss.35-38, 2011 (SCI-Expanded, Scopus)

75. Colonization and resistance patterns of gram-positive and gram-negative bacteria in patients had no recent history of hospitalization

KURTARAN B., TAŞOVA Y., KİBAR F., Candevir A., SEYDAOĞLU G., AKYILDIZ O., et al.

Infectious Diseases in Clinical Practice , cilt.19, sa.2, ss.105-110, 2011 (SCI-Expanded, Scopus)

76. Invasive device-associated nosocomial infections of a teaching hospital in Turkey; four years' experience

Candevir A., Kurtaran B., Kibar F., Karakoç E., Aksu H. S. Z., Taşova Y.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.41, sa.1, ss.137-147, 2011 (SCI-Expanded, Scopus, TRDizin)

77. Tetanus in an intensive care unit of a Turkish hospital: Patient analysis of a 6-year period

KURTARAN B., KARAKOÇ E., Candevir A., Komur S., İNAL A. S., KİBAR F., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.40, sa.1, ss.121-126, 2010 (SCI-Expanded, Scopus, TRDizin)

78. Renal transplantasyon sonrası erken dönemde görülen üriner sistem infeksiyonlarının epidemiyolojisi ve risk faktörleri

AYTUTULDU A., KURTARAN B., PAYDAŞ S., CANDEVİR A., BALAL M., DEMİR E., et al.

ANKEM DERGİSİ , cilt.24, sa.4, ss.220-226, 2010 (TRDizin)

Yayınlar & Eserler